Preview

South Russian Journal of Cancer

Advanced search

TREATMENT OF LOCALIZED RENAL CANCER

https://doi.org/10.37748/2687-0533-2020-1-1-6

Abstract

Renal cell carcinoma (RCC) accounts for 3.9 % of all cancers. In 2018, 24,291 and 63,990 new cases of RCC were recorded in Russia and the US, respectively. The most common approach to early stage RCC treatment consists in either radical or partial nephrectomy. This article presents a clinical case of the successful treatment of a localized renal cell carcinoma T3аN0M0 in a 65-year-old man. 8 weeks after the performed kidney resection, the biochemical blood parameters and glomerular filtration rate did not significantly differ from the initial values (p > 0.05). A control CT examination of the abdominal cavity and the retroperitoneal space (after 12 weeks) detected no enlarged regional, paraaortic and paracanal lymph nodes. Partial nephrectomy is considered to be an alternative surgical treatment of localized RCC forms due to its potential for maximal organ preservation. Partial nephrectomy should be a method of choice in cases where it is technically and strategically feasible, since this type of surgical intervention provides for a better preservation of renal function under a lower risk of postoperative complications.

About the Author

N. G. Kulchenko
Peoples Friendship University of Russia (RUDN University)
Russian Federation

Nina G. Kulchenko — Cand. Sci. (Med.), Urologist, Senior Lecturer, Department of Histology, Cytology and Embryology

6 Miklukho-Maklaja str., Moscow 117198

SPIN: 1899-7871   



References

1. Safronova E.Yu., Nushko K. M., Alekseev B. Ya., Kalpinskiy A. S., Polyakov V. A., Kaprin A. D. Methods of performing of hemost asis during kidney resection. Research and Practical Medicine Journal. 2016;3(1):58–65 (In Russian). https://doi.org/10.17709/2409–2231–2016–3-1–8

2. Kriegmair M. C., Bertolo R., Karakiewicz P. I., Leibovich B. C., Ljungberg B., Mir M. C., et al. Systematic Review of the Management of Local Kidney Cancer Relapse. Eur Urol Oncol. 2018;1(6):512–523. https://doi.org/10.1016/j.euo.2018.06.007

3. Minervini A., Campi R., Mari A., Antonelli A. Re: Renal Cancer Surgery for Patients Without Preexisting Chronic Kidney Disease: Is There a Survival Benefit for Partial Nephrectomy? European Urology. 2019 May;76(3):407–408. https://doi.org/10.1016/j.eururo.2019.05.021

4. Alekseev B.Ya., Kalpinskiy A. S., Taraki I. A., Mukhomed’yarova A. A., Nyushko K. М., Vorobyev N. V., et al. Possibilities of organpreserving treatment of patients with multiple renal tumors. Research and Practical Medicine Journal. 2017;4(2):54–60 (In Russian). https://doi.org/10.17709/2409–2231–2017–4-2–7

5. Porta C., Cosmai L., Leibovich B. C., Powles T., Gallieni M., Bex A. The adjuvant treatment of kidney cancer: a multidisciplinary outlook. Nat Rev Nephrol. 2019 Jul;15(7):423–433. https://doi.org/10.1038/s41581–019–0131-x

6. Lam J. S., Leppert J. T., Figlin R. A., Belldegrun A. S. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Current Urology Reports. 2005;6(1):7–18. https://doi.org/10.1007/s11934–005–0062-x

7. Huang W. C., Levey A. S., Serio A. M., Snyder M., Vickers A. J., Raj G. V., et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006 Sep;7(9):735–740. https://doi.org/10.1016/S1470–2045(06)70803–8

8. Ljungberg B., Bensalah K., Canfield S., Dabestani S., Hofmann F., Hora M., et al. EAU Guidelines on Renal Cell Carcinoma: 2014 Update. European Urology. 2015;67(5):913–924. https://doi.org/10.1016/j.eururo.2015.01.005

9. Kim S. P., Thompson R. H., Boorjian S. A., Weight C. J., Han L. C., Murad M. H., et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012 Jul;188(1):51–57. https://doi.org/10.1016/j.juro.2012.03.006

10. Smaldone M. C., Kutikov A., Egleston B., Simhan J., Canter D. J., Teper E., et al. Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology. 2012 Aug;80(2):286–291. https://doi.org/10.1016/j.urology.2012.02.067

11. Andrews J. R., Atwell T., Schmit G., Lohse C. M., Kurup A. N., Weisbrod A., et al. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol. 2019 Aug;76(2):244–251. https://doi.org/10.1016/j.eururo.2019.04.026

12. Kane C. J., Mallin K., Ritchey J., Cooperberg M. R., Carroll P. R. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008 Jul;113(1):78–83. https://doi.org/10.1002/cncr.23518

13. Shvero A., Nativ O., Abu-Ghanem Y., Zilberman D., Zaher B., Levitt M., et al. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer. Clin Genitourin Cancer. 2018;16(3): e613–e617. https://doi.org/10.1016/j.clgc.2017.10.016

14. Lau W. K., Blute M. L., Weaver A. L., Torres V. E., Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000 Dec;75(12):1236–1242. https://doi.org/10.4065/75.12.1236

15. Van Poppel H., Da Pozzo L., Albrecht W., Matveev V., Bono A., Borkowski A., et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011 Apr;59(4):543–552. https://doi.org/10.1016/j.eururo.2010.12.013

16. Bertolo R., Garisto J., Sagalovich D., Dagenais J., Agudelo J., Kaouk J. Achieving tumour control when suspecting sinus fat involvement during robot-assisted partial nephrectomy: step-by-step. BJU International. 2019;123(3):548–556. https://doi.org/10.1111/bju.14552

17. An J. Y., Ball M. W., Gorin M. A., Hong J. J., Johnson M. H., Pavlovich C. P., et al. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes. Urology. 2017 Feb;100:151–157. https://doi.org/10.1016/j.urology.2016.10.047

18. Mir M. C., Derweesh I., Porpiglia F., Zargar H., Mottrie A., Autorino R. Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies. Eur Urol. 2017;71(4):606–617. https://doi.org/10.1016/j.eururo.2017.06.005


Review

For citations:


Kulchenko N.G. TREATMENT OF LOCALIZED RENAL CANCER. South Russian Journal of Cancer. 2020;1(1):69-75. (In Russ.) https://doi.org/10.37748/2687-0533-2020-1-1-6

Views: 1667


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2686-9039 (Online)